AMENDMENTTO DEBENTURE OF FIXED CHARGE

EX-10.4 5 s103470_ex10-4.htm EXHIBIT 10-4

 

Exhibit 10.4

 

AMENDMENT TO DEBENTURE OF FIXED CHARGE

 

This amendment (the “Amendment”) to the Debenture of Fixed Charge dated October 23, 2013, as amended, modified, restated, replaced or supplemented and as may be further amended, modified, restated, replaced or supplemented from time to time in accordance with its terms (the “Debenture”) is made as of June 13, 2016 by and among Inspire M.D Ltd., a limited liability company organised and existing under the laws of the State of Israel with its registered office at 4 Menorat Hamaor St., Tel Aviv, 6744831, Israel, company number 51-367943-1 (the “Pledgor”), and Hercules Capital, Inc., a Maryland corporation with its registered office at 400 Hamilton Avenue, Suite 310, Palo Alto, California 94301 (the “Lender”) and Hercules Capital, Inc., a Maryland corporation with its registered office at 400 Hamilton Avenue, Suite 310, Palo Alto, California 94301 in its capacity as administrative agent for itself and the Lenders under the Loan Agreement (in such capacity, the “Agent”). All terms capitalized and not otherwise defined hereunder shall have the meanings assigned to such terms under the Debenture.

 

WHEREAS, the Lender, the Pledgor and the its parent company InspireMD, Inc. have entered into that certain loan arrangement dated as of October 23, 2013, evidenced by, among other documents, a certain Loan and Security Agreement dated as of October 23, 2013 (hereinafter, as may be amended, restated, replaced or supplemented from time to time in accordance with its terms, and together with the Loan Documents (as defined thereunder), collectively, the “Loan Agreement”) and in connection with that Loan Agreement, the Pledgor and the Lender wish to amend the provisions of the Debenture as set forth herein.

 

NOW THEREFORE, the Parties agree as follows:

 

1.Description of Change in Terms:

 

A.The first paragraph of the preamble shall be replaced in its entirety with the following:

 

“WHEREAS, the undersigned, Inspire M.D Ltd, a limited liability company organised and existing under the laws of the State of Israel with its registered office at 4 Menorat Hamaor St., Tel Aviv, 6744831, Israel (hereinafter: the “Pledgor”), intends to receive, jointly and severally with its parent company, InspireMD, Inc. (hereinafter: the “Parent”) from several banks and other financial institutions or entities from time to time parties to the Loan Agreement (as defined below) (collectively, the “Lender”), including Hercules Capital, Inc., a Maryland corporation with its registered office at 400 Hamilton Avenue, Suite 310, Palo Alto, California 94301 in its capacity as administrative agent for itself and the Lenders (in such capacity, the “Agent”), a loan or loans, for such purpose and on such conditions as specified in the provisions of that certain Loan and Security Agreement entered into between and among the Lenders, the Pledgor and the Parent on October 23rd, 2013, as amended from time to time (hereinafter, as may be amended, restated, replaced or supplemented from time to time in accordance with its terms, and together with the Loan Documents (as defined thereunder), collectively, the “Loan Agreement”);”

 

 

 

 

B.Section 2 of the Debenture shall be replaced in its entirety with the following:

 

"     2.        As collateral security for the full and punctual payment of all of the Secured Sums (whether at stated maturity, acceleration or otherwise), and without derogating from any other security, the Pledgor hereby absolutely and unconditionally charges and pledges to the Lender and its successors by way of a first ranking fixed charge and pledge, and by an assignment by way of pledge, as applicable, (A) (i) all Pledgor's rights to receive funds from its customers listed under Appendix A attached hereto (the “Customers List”), and (ii) each outstanding account as specified in Appendix B attached hereto (the “Pledged Accounts”), and (B) all Pledgor's rights, whether now existing or thereafter created (i) in and to all copyright rights, copyright applications, copyright registrations and like protections in each work of authorship and derivative work thereof, whether published or unpublished, and whether or not the same also constitutes a trade secret, now or hereafter existing, created, acquired or held (“Copyrights”), including without limitation as specified in Appendix C attached hereto; (ii) in and to all patents, patent applications and like protections, including without limitation improvements, divisions, continuations, renewals, reissues, extensions, and continuations-in-part of the same (“Patents”), including without limitation as specified in Appendix D attached hereto; (iii) in and to all trademark and service mark rights, whether registered or not, applications to register and registrations of the same and like protections, and the entire goodwill of the business of Pledgor connected with and symbolized by such trademarks (“Trademarks”), including without limitation as specified in Appendix E attached hereto; (iv) in and to all mask works or similar rights available for the protection of semiconductor chips, now owned or hereafter acquired (“Mask Works”), including, without limitation as specified in Appendix F; (v) in and to all trade secrets and trade secret rights, including, without limitation, any rights to unpatented inventions, know-how, operating manuals; (vi) in and to all source code; (vii) in and to all design rights; (viii) in and to all claims for damages by way of past, present and future infringement of any of the foregoing, with the right, but not the obligation, to sue for and collect such damages for said use or infringement of the intellectual property rights identified above; and (ix) in and to all trade secrets, and any and all intellectual property rights in computer software and computer software products now or hereafter existing, created, acquired or held; (x) in and to all amendments, renewals and extensions of any of the Copyrights, Trademarks, Patents and Mask Works; in all cases whether now owned or hereafter acquired by Pledgor; (xi) in and to all licenses or other rights to use any of the Copyrights, Patents, Trademarks, or Mask Works and all license fees and royalties arising from such use to the extent permitted by such license or rights; (xii) to all proceeds and products of the foregoing, including, without limitation, all payments under insurance or any indemnity or warranty payable in respect of any of the foregoing; and (C) all the fixed assets listed under Appendix G (the “Equipment List”) (hereinafter (A), (B) and (C), jointly and severally, the "Charged Property”).

 

It is hereby agreed and acknowledged that the description of the Charged Property, including without limitations, the Customers List, Pledged Accounts, Copyrights, Patents, Trademarks, Mask Works and Equipment List, shall be amended and updated from time to time by the Pledgor, in accordance with the provisions hereof and the provisions of the Loan Agreement."

 

C.The following shall be added as Section 33 of the Debenture:

 

"            AGENCY

 

33.          Lenders hereby irrevocably appoints Hercules Capital, Inc. to act on their behalf as the administrative agent for itself and the Lenders (in such capacity, the “Agent”) hereunder and authorizes the Agent to take such actions on its behalf and to exercise such powers as are delegated to the Agent by the terms hereof or thereof, together with such actions and powers as are reasonably incidental thereto. It is hereby noted that all rights granted herein to the Lender shall be deemed as granted to the Agent for the ratable benefit of the Lenders.”

 

2.The above mentioned Appendixes shall be attached hereto as integral part hereof and as integral part of the Debenture.

 

 

 

 

3.Except as specifically set forth herein, none of the terms of the Debenture shall be in any way modified by this Amendment, and all such terms and conditions shall remain in full force and effect.

 

4.This Addendum is made in accordance with Section 29 of the Debenture, and constitutes (together with any appendix attached hereof) an integral part thereof.

 

-signature page follows-

 

 

 

 

IN WITNESS WHEREOF, the parties have caused this Amendment to be signed on the date first above written.

 

/s/ Ben Bang  
HERCULES CAPITAL, INC. [also in its capacity as Agent]  
By: Ben Bang  
Title: Associate General Counsel  
     
/s/ Craig Shore  
INSPIRE M.D LTD  
By: Craig Shore  
Title: CFO  

 

 

 

 

Appendix A
Customers List

 

Company   Country
CMS Produtos Medicos Ltda (OLD)   Brazil
Dispomed Promet   Croatia
Medreto OU   Estonia
Dr. Osypka GmbH   Germany
Tzamal Jakobsohn Ltd   Israel
KIRLOSKAR TECHNOLOGIES (P) LTD   India
Euromed GmbH   Austria
Sigma Medical B.V.   Netherlands
Bosti Trading Ltd.   Cyprus
Dream Technology L.P.   United Kingdom
Charles de Giorgio Ltd.   Malta
Premier G. Med Cardio Ltd   Hungary
Torque Medical   South Africa
Stimcare   Czech Republic
Fortimed   Spain
Grex Medical Oy   Finland
Tecmed SRL   Romania
Vascular Perspectives Ltd   United Kingdom
Meliora Medtech AB   Sweden
lnselspital Bern   Switzerland
Hospital Fribourgeols   Switzerland
Chi Le Raincy Montfermeil   France
Groupe Hospitalier Mutualiste   France
CHUV   Switzerland
Bay Medical Pty Ltd   Australia
CENTRE HOSPITALIER D AVIGNON   France
GlobalMed a.s.   Slovakia
Universitatsmedizin Rostock   Germany
CMS Chile   Chile
CHU Besancon (not active)   France
CH Haguenau   France
PLN Szpital Uniwersytecki w Krakowie   Poland
Katedra i Klinika Kardiologii Uniwersytetu Medyc   Poland
University Hospitals Southampton NHS Foundation   United Kingdom
Vingmed AS. Norway   Norway
KAUF Klinikum Fulda gAG   Germany
Clinique Pasteur   France
SLK Kliniken Heilbronn GmbH   Germany
Centre Hospitalier de la region Anneciennc   France
Charite - Universitatsmedizin Berlin - CVK   Germany
Kardiologische Praxis Prof. Dr. Silber   Germany

 

 

 

lnstitut Jacques Cartier   France
HJK Erkelenz/Am Schneller   Germany
Centre Hospitalier de LA CAVALE BLANCHE   France
CHU Jean Minjoz Besancon   France
SPZOZ, Pracownia Hemodynamiki   Poland
Waldkrankenhaus   Germany
SAS CLINIQUE GENERALE DE MARIGNANE   France
Antwerp Cardiovascular Institute, AZ Middelheim   Belgium
G.C.S. Cardio CHRA   France
Krakowskie Centrum Kardiologii   Poland
CHU Gabriel Montpied   France
Clinique Saint-Vincent   France
Sana-Herzzentrum Cottbus GmbH   Germany
Herzzentrum Dresden GmbH   Germany
Cardiology Associates of North MS/Research, LLC   United States
SIA Scanmed   Latvia
CARDIO MEDICAL D.O.O.   Slovenia
Unfallkrankenhaus Berlin   Germany
Vingmcd Sweden   Sweden
polyclinique des fleurs   France
Medilex Limited   Ireland
Hopital Claude Galien ICPS   France
Sz.P. Wieslaw Mazurek   Poland
Hopital haut leveque-CHU de Bordeaux   France
CHU de Toulouse hopital de Rangueil   France
Kardia   Italy
Uniwersytecki Szpital Kliniczny   Poland
Avidal Group GMBH   Germany
JSC Medikamcntu tinklas Co.   Lithuania
HELIOS Klinikum Aue   Germany
Uniwersyteckie Centrum Kliniczne   Poland
Wojskowym Instytutem Medycznym   Poland
Izasa Hospital SLU   Spain
Uniwersytetu Medycznego w Lodzi   Poland
Klinika Kardiologii i Angiologii Interwencyjnej   Poland
Charite Universitatsklinikum Berlin Campus Virch   Germany
Charite Universitatsklinikum Berlin Campus Benja   Germany
Cardiff University Hospitals   United Kingdom
Sheffield Teaching Hospitals   United Kingdom
Universitatsklinikum Magdeburg A.o.R.   Germany
Petr Jerabek   Czech Republic
Jan Winten   Belgium
Christopher MacLeod   United Kingdom
Miki Olsher   Israel
Stephane Viney   France
Vivianc Barbieri   Brazil

 

 

 

Dominika Chudzik   Poland
Eduard Kasper   Germany
Paul Jeffers   United Kingdom
Jane Bettoni   Italy
Sieglinde Reik-Lingen   Germany
Piet van den Bosch   Netherlands
Juan Rigla   Spain
Kim Vandeweyer   Belgium
Rick Olson   United Kingdom
Pavel Minkov   Israel
Ralph Essers   Netherlands
Jens Ten Doornkaat   Germany
Giancarlo Fasulo   Italy
TIP Profiles Karolina Mendocha   Poland
Augusta-Krankcnhaus VKKD   Germany
Logis-Med Sp. Zo.o.   Poland
VASMO Medical Group   Poland
Centre Hospitalier St. Joseph et st Luc 2   France
Avidal Group GMBH as Agent   Germany
Klinikum Stadt Soest   Germany
Herz- und Diabeteszentrum NRW   Germany
Manchester Royal Infirmary   United Kingdom
Austro Line d.o.o.   Monaco
I.R.C.C.S. Policlinico San Donato   Italy
Azienda ULSS 13 MIRANO Regione Veneta   Italy
Hairmyres NHS Trust OCT   United Kingdom
Sheba Medical Center   Israel
Stefano Cova   Italy
Herzklinik Dres Harer   Germany
Sunderland Hospital   United Kingdom
CARDIO MEDICAL SALES L.P.   Lithuania
Nathalie Barthelemy   France
MCZ-Hemodynamika   Poland
Kaster Srl   Italy
Norfolk and Norwich University Hospital- OCT   United Kingdom
Morriston Hospital- OCT   United Kingdom
Papworth Hospital NHS Foundation Trust- OCT   United Kingdom
University Hospitals of South Manchester- OCT   United Kingdom
Hairmyres NHS Trust   United Kingdom
Freeman Hospital   United Kingdom
SAMODZIELNY PUBLICZNY ZOZ WOJE   Poland
Shaare Zedek Medical Center   Israel
מ”עבעשירא   Israel
CROSSMED S.r.1.   Italy
Carlos Haya Hospital   Spain
LMR A.O.U. Citta delta Salute e della   Italy

 

 

 

LMR Ospedale Policlinico Santa Maria   Italy
Cyvital Enterprises Limited   Cyprus
Piotr Musialek   Poland
ULSS 13 Mirano - Presidio de Mirano - LMR   Italy
Pauls Stradins Clinical University Hospital -LMR   Latvia
VIDE BULA   Brazil
E-Symbion SRL   Romania
ProCardia Medical Sp. z o.o.   Poland
Carmel Medical Center   Israel
Prof. Schofer   Poland
Rothschild Hospital   France
CHU Grenoble   France
INMED Com. de Mat. Hosp. Ltda   Brazil
INTUIT   Brazil
TECNOMEDICAL   Brazil
Somma Produtos Hospitalares LTDA   Brazil
Penumbra Europe GmbH   Germany
Endovix   Brazil
The Queen Elizabeth University Hospital   United Kingdom
SUPRI Medical and Hospital Devices Ltda   Brazil
WORLD MEDICAL S.A.S.   Colombia
lmportadora y Exportadora CAMIR LTDA   Chile
Pro Gem   Slovenia
Osypka AG   Germany
Barts and The London NHS Trust   United Kingdom
Med-All International   Germany
Mediscape   Malaysia
Angiocor S.A.   Argentina
Svelte Medical Systems, Inc.   United States
EURO MEKO   Germany
QUALIMED   Germany
BCH   Canada
Natec Medical Ltd.   Mauritius
Cardiovascular Interventional Concepts (CIC)   Brazil
LEVBETH MEDICAL SA DE CV   Mexico
MedlineS Kft.   Hungary
KEBOMED AS   Denmark
Endo Tech s.r.o   Czech Republic

 

[END OF EXHIBIT A]

 

 

 

Appendix B

Pledged Accounts

 

Det Trial Bal: Acct Curr & USD

6/8/2016

 

Curr  Account No.   Account Description  Balance (ILS)   Bal (USD)   Bal (Acct Curr)   Curr
1**.ASSETS                      
10*.CURRENT ASSETS                      
104.Accounts Receivable- Clients                  
    100021   Tzamal Jakobsohn Ltd   243,941.71    64,338.97         
Total           243,941.71    64,338.97    0    
CHF   100068   CHUV   3,746.60    996.17    963.36   CHF
Total           3,746.60    996.17    963.36   CHF
EUR   100015   Medreto OU   1,711.52    453.98    400   EUR
    100036   Bosti Trading Ltd.   -31,014.72    -8,246.40    -7,260.51   EUR
    100054   Torque Medical   -137.76    -17.98        EUR
    100057   Grex Medical Oy   -427.17    -113.58    -100   EUR
    100058   Tecmed SRL   22,499.75    5,929.17    5,250.00   EUR
    100071   GlobalMed a.s.   30,772.13    8,093.11    7,145.00   EUR
    100097   Institut Jacques Cartier   5,094.19    1,347.06    1,185.78   EUR
    100121   G.C.S. Cardio CHRA   9,256.31    2,467.07    2,171.56   EUR
    100137   polyclinique des fleurs   -115.81    -30.79    -27.11   EUR
    100139   Hopital Claude Galien ICPS   4,210.96    1,119.64    985.78   EUR
    100142   Hopital haut leveque-CHU de Bordeaux   4,168.82    1,119.50    985.78   EUR
    100144   Kardia   67,940.45    18,064.46    15,904.78   EUR
    100146   Avidal Group GMBH   80,372.52    20,931.35    18,700.00   EUR
    100159   Izasa Hospital SLU   108,984.02    28,689.59    25,320.00   EUR
    100229   Centre Hospitalier St. Joseph et st Luc 2   2,121.10    560.55    492.89   EUR
    100230   Avidal Group GMBH as Agent   2,801.51    716.5    658.45   EUR
    100249   Kaster Srl   124,500.75    33,366.48    29,150.00   EUR
    100262   CROSSMED S.r.l.   118,126.56    30,948.36    27,360.00   EUR
    100266   Cyvital Enterprises Limited   6,806.32    1,820.58    1,600.00   EUR
    100293   MedlineS Kft.   -3,359.23    -736.02    -786.53   EUR
    100295   Endo Tech s.r.o   -59.9    -14.42        EUR
Total           554,252.32    146,468.21    129,135.87   EUR
GBP   100254   Hairmyres NHS Trust   118.43    31.49    21.59   GBP
    100255   Freeman Hospital   -3,250.20    -831.25    -600   GBP
    100297   Asteral Services Ltd   428.05    114.24    78   GBP
Total           -2,703.72    -685.52    -500.41   GBP
PLN   100227   Logis-Med Sp. Z o.o.   -7,209.62    -1,843.89    -7,250.00   PLN
Total           -7,209.62    -1,843.89    -7,250.00   PLN
USD   100050   Temp USD   -165.48    -44    -44   USD
    100129   SIA Scanmed   31,451.49    8,237.50    8,237.50   USD
    100243   CARDIO MEDICAL SALES L.P   525,895.00    134,500.00    134,500.00   USD
    100285   Penumbra Europe GmbH   132,652.31    30,615.00    30,615.00   USD
    100288   SUPRI Medical and Hospital Devices Ltda   -166.95    0        USD
    100291   Cardiovascular Interventional Concepts (CIC)   133    0        USD
    100292   LEVBETH MEDICAL SA DE CV   4,270.20    0        USD
    100294   KEBOMED AS   43,968.65    11,000.00    11,000.00   USD
    207136   provision for returns   75.22    20    20   USD
    300023   Angiocor S.A   102,527.00    27,000.00    27,000.00   USD
Total           840,640.44    211,328.50    211,328.50   USD
105.Accounts Receivable- Doubtful                  
EUR   100027   Novalab France   266,498.55    70,858.43    62,387.00   EUR
    100028   Euromed Deutschland GmbH   748,246.48    198,948.81    175,163.63   EUR
    100029   Euromed GmbH   23,921.52    6,360.41    5,600.00   EUR
    100034   Slainte Solutions Ltd   62,443.71    16,602.95    14,618.00   EUR
    101111   Provision for bad debts Euro   -1,101,239.86    -292,805.07    -257,798.97   EUR
Total           -129.6    -34.47    -30.34   EUR
GBP   100190   Cardiff University Hospitals   3,016.86    802.14    550   GBP
    101112   Provision for bad debts GBP   -3,016.86    -802.14    -550   GBP
Total           0    0    0   GBP
USD   100273   E-Symbion SRL   18,924.14    5,021.00    5,021.00   USD
    101113   Provision for bad debts $   -18,883.98    -5,021.00    -5,021.00   USD
Total           40.16    0    0   USD
TOTAL           1,632,578.29    420,567.97        USD

 

 

 

 

Appendix C

Copyrights

 

None.

 

 

 

 

Appendix D

Patents

 

Description   Registration/
Application
Number (Country)
  Registration/
Application
Date
         
Optimized Stent Jacket   198,665 (IL)   Nov. 21, 2007; issued May 28, 2014
         
Optimized Stent Jacket   ZL200780043259.2 (CN)   Nov. 21, 2007; issued Jan. 2, 2013
         
Optimized Drug-Eluting Stent Assembly   9,132,003 (US); 14/314,777   June 24, 2014; issued Jan. 2, 2013
         
Optimized Stent Jacket   ZL201210454357.8 (CN)   Nov. 13, 2013; issued Dec. 9, 2015
         
Bifurcated Stent Assemblies   198,188 (IL)   Oct. 18, 2007; issued May 1, 2014
         
In Vivo Filter Assembly   8,043,323 (US); 11/582,354   Oct. 18, 2006; issued Oct. 25, 2011
         
Bifurcated Stent Assemblies   8,961,586 (US); 11/797,168   May 1, 2007; issued Feb. 24, 2015
         
In Vivo Filter Assembly   9,132,261 (US); 13/237,977   Sept. 21, 2011; issued Sept. 15, 2015
         
Bifurcated Stent Assemblies   ZL200780046676.2 (CN)   Issued Sept. 26, 2012
         
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use   2,609,687 (CA)   May 24, 2006; issued April 22, 2014
         
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use   2,843,097 (CA)   Feb. 20, 2014; issued Oct. 27, 2015
         
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use   2007/10751 (ZA)   Issued Oct. 27, 2010
         
Filter Assemblies   198189 (IL)   Oct. 18, 2007; issued Mar. 27, 2014

 

 

 

 

Filter Assemblies   2,666,712 (CA)   Oct. 18, 2007; issued Mar. 31, 2015
         
Filter Assemblies   ZL200780046659.9 (CN)   Oct. 18, 2007; issued Mar. 31, 2015
         
Filter Assemblies   201210119132.7 (CN)   Oct. 18, 2007
         
Knitted Stent Jackets   198190 (IL)   Oct. 18, 2007; issued Feb. 1, 2014
         
Knitted Stent Jackets   ZL200780046697.4 (CN)   Issued Oct. 10, 2012; expires Oct. 17, 2027
         
Knitted Stent Jackets   2,666,728 (CA)   Oct. 18, 2007; issued June 23, 2015
         
Knitted Stent Jackets   ZL201210320950.3 (CN)   Oct. 18, 2007; issued Dec. 2, 2015
         
Stent with Sheath and Metal Wire   14/315,001 (US); 2014/0309723   June 25, 2014
         
Stent with Sheath and Metal Wire and Methods   14/705,871 (US); 2015/0230953   May 6, 2015
         
Optimized Stent Jacket   12/791,008 (US); 2010/0241214   June 1, 2010
         
Intravascular Aneurysm Treatment Device And Methods   14/935,339 (US); 2016/0058589   Nov. 6, 2015
         
Optimized Stent Jacket   07827415.6 (EP); EP2088962 A4   Nov. 21, 2007
         
Optimized Stent Jacket   230922 (IL)   Feb. 11, 2014
         
Optimized Stent Jacket   2,670,724 (CA)   Nov. 21, 2007
         
Optimized Stent Jacket   4008/DELNP/2009 (IN)   Nov. 21, 2007
         
Optimized Drug-Eluting Stent Assembly   14/851,882 (US); 2015/0374519   Sept. 11, 2015
         
Bifurcated Stent Assemblies   3113/DELNP/2009 (IN)   Oct. 18, 2007
         
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use   EP 06745069.2 (EP); EP1885281 A2   May 24, 2006

 

 

 

 

Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use   11/920,972 (US); 2009/0138070   Nov. 23, 2007
         
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use   187516 (IL)   Nov. 20, 2007
         
Carotid Stent Assembly and Methods for Treatment Via Body Lumens   14/500,759 (US); 2015/0032197   Sept. 29, 2014
         
Filter Assemblies   EP 2007 827228.3 (EP)   Oct. 18, 2007
         
Filter Assemblies   12/445,972 (US); 2010/0204772   Apr. 17, 2009
         
Filter Assemblies   2,881,557 (CA)   Feb. 6, 2015
         
Filter Assemblies   3114/DELNP/2009 (IN)   Oct. 18, 2007
         
Knitted Stent Jackets   EP 07827229.1 (EP); EP ###-###-#### A2   Oct. 18, 2005
         
Knitted Stent Jackets   12/445,980 (US); 2010/0324651   Apr. 17, 2009
         
Knitted Stent Jackets   3171/DELNP/2009 (IN)   Oct. 18, 2007
         
Knitted Stent Jackets   2,887,189 (CA)   Apr. 2, 2015
         
Stent Thermoforming Apparatus and Methods   14/505,310 (US); 2016/0096308   Oct. 2, 2014
         
Stent Thermoforming Apparatus and Methods   PCT/IB2015/057367   Sept. 24, 2015
         
Stent-Mesh Assembly And Methods   14/592,714 (US); 2015/0119971   Jan. 8, 2015
         
Stent with Sheath and Metal Wire Retainer   13/994,739 (US); 2013/0274858   Dec. 18, 2011
         
Deformable Tip For Stent Delivery And Methods Of Use   62/290,031 (US)   Feb. 2, 2016

 

[END OF EXHIBIT D]

 

 

 

 

Appendix E

Trademarks

 

Description   Registration/
Application
Number (Country)
  Registration/
Application
Date
         
CARENET   013399977 (EU)   Mar. 17, 2015
         
CGUARD   013370978 (EU)   Mar. 26, 2015
         
INSPIREMD   008642118 (EU)   Apr. 26, 2010
         
MGUARD   008642175 (EU)   Apr. 26, 2010
         
MGUARD PRIME   013366141 (EU)   Mar. 12, 2015
         

MICRONET (Class 10) (Supplemental Registration)

  4,721,716 (US); 85/659,900   Apr. 14, 2015
         
MNP MicroNet Protection Logo   011737699 (EU)   Sept. 9, 2013
         
CARENET   86/261,697 (US)   Apr. 24, 2014
         
CGuard   86/364,984 (US)   Aug. 13, 2014
         
MGUARD PRIME   86/417,711 (US)   Oct. 8, 2014
         
InspireMD   86/702,932 (US)   July 23, 2015
         
SmartFit   86/702,941 (US)   July 23, 2015
         
PVGuard   86/702,984 (US)   July 23, 2015
         
NGuard   86/702,957 (US)   July 23, 2015
         
AGuard   86/702,971 (US)   July 23, 2015

 

 

 

 

Appendix F

Mask Works

 

None.

 

 

 

 

Appendix G

Equipment List

 

Distributed via e-mail.